Young, Jim

van Santen, Daniela K; Stewart, Ashleigh; Doyle, Joseph S; Stoové, Mark A; Asselin, Jason; Klein, Marina B; Young, Jim; Berenguer, Juan; Jarrin, Inmaculada; Lacombe, Karine; Wittkop, Linda; Leleux, Olivier; Salmon, Dominique; Bonnet, Fabrice; Rauch, Andri; Mugglin, Catrina; Matthews, Gail; Prins, Maria; Smit, Colette; Boyd, Anders; ... (2024). Cohort Profile: International Collaboration on Hepatitis C Elimination in HIV Cohorts (InCHEHC). International journal of epidemiology, 53(1) Oxford University Press 10.1093/ije/dyad154

Sacks-Davis, Rachel; van Santen, Daniela K; Boyd, Anders; Young, Jim; Stewart, Ashleigh; Doyle, Joseph S; Rauch, Andri; Mugglin, Catrina; Klein, Marina; van der Valk, Marc; Smit, Colette; Jarrin, Inmaculada; Berenguer, Juan; Lacombe, Karine; Requena, Maria-Bernarda; Wittkop, Linda; Leleux, Olivier; Bonnet, Fabrice; Salmon, Dominique; Matthews, Gail V; ... (2024). Changes in incidence of hepatitis C virus reinfection and access to direct-acting antiviral therapies in people with HIV from six countries, 2010-19: an analysis of data from a consortium of prospective cohort studies. The Lancet HIV, 11(2), e106-e116. Elsevier 10.1016/S2352-3018(23)00267-9

van Santen, Daniela K; Sacks-Davis, Rachel; Stewart, Ashleigh; Boyd, Anders; Young, Jim; van der Valk, Marc; Smit, Colette; Rauch, Andri; Braun, Dominique L; Jarrin, Inmaculada; Berenguer, Juan; Lazarus, Jeffrey V; Lacombe, Karine; Requena, Maria-Bernarda; Wittkop, Linda; Leleux, Olivier; Salmon, Dominique; Bonnet, Fabrice; Matthews, Gail; Doyle, Joseph S; ... (2023). Treatment as prevention effect of direct-acting antivirals on primary hepatitis C virus incidence: Findings from a multinational cohort between 2010 and 2019. EClinicalMedicine, 56, p. 101810. Elsevier 10.1016/j.eclinm.2022.101810

Young, Jim; Scherrer, Alexandra U; Calmy, Alexandra; Tarr, Philip E; Bernasconi, Enos; Cavassini, Matthias; Hachfeld, Anna; Vernazza, Pietro; Günthard, Huldrych F; Bucher, Heiner C (2019). The comparative effectiveness of NRTI-sparing dual regimens in emulated trials using observational data from the Swiss HIV Cohort Study. Antiviral therapy, 24(5), pp. 343-353. International Medical Press 10.3851/IMP3310

Prague, Mélanie; Commenges, Daniel; Gran, Jon Michael; Ledergerber, Bruno; Young, Jim; Thiébaut, Rodolphe; Furrer, Hansjakob (2017). Dynamic models for estimating the effect of HAART on CD4 in observational studies: Application to the Aquitaine Cohort and the Swiss HIV Cohort Study. Biometrics, 73(1), pp. 294-304. The International Biometric Society 10.1111/biom.12564

Schäfer, Juliane; Young, Jim; Calmy, Alexandra; Nicca, Dunja; Hasse, Barbara; Brun del Re, Claudia; Cavassini, Matthias; Bernasconi, Enos; Schmidt-Trucksäss, Arno; Bucher, Heiner C (2017). High prevalence of physical inactivity among patients from the Swiss HIV Cohort Study. AIDS Care-Psychological and Socio-Medical Aspects of AIDS/HIV, 29(8), pp. 1056-1061. Taylor & Francis 10.1080/09540121.2016.1274016

Shilaih, Mohaned; Marzel, Alex; Braun, Dominique L; Scherrer, Alexandra U; Kovari, Helen; Young, Jim; Calmy, Alexandra; Darling, Katharine; Battegay, Manuel; Hoffmann, Matthias; Bernasconi, Enos; Thurnheer Zürcher, Maria Christine; Günthard, Huldrych F; Kouyos, Roger D (2017). Factors associated with syphilis incidence in the HIV-infected in the era of highly active antiretrovirals. Medicine, 96(2), e5849. Lippincott Williams & Wilkins 10.1097/MD.0000000000005849

Young, Jim; Xiao, Yongling; Moodie, Erica E M; Abrahamowicz, Michal; Klein, Marina B; Bernasconi, Enos; Schmid, Patrick; Calmy, Alexandra; Cavassini, Matthias; Cusini, Alexia; Weber, Rainer; Bucher, Heiner C (2015). The effect of cumulating exposure to abacavir on the risk of cardiovascular disease events in patients from the Swiss HIV Cohort Study. Journal of acquired immune deficiency syndromes JAIDS, 69(4), pp. 413-421. Lippincott Williams & Wilkins 10.1097/QAI.0000000000000662

Young, Jim; Rickenbach, Martin; Calmy, Alexandra; Bernasconi, Enos; Stähelin, Cornelia Johanna; Schmid, Patrick; Cavassini, Matthias; Battegay, Manuel; Günthard, Huldrych F; Bucher, Heiner C (2015). Transient detectable viremia and the risk of viral rebound in patients from the Swiss HIV Cohort Study. BMC infectious diseases, 15(1), p. 382. BioMed Central 10.1186/s12879-015-1120-8

Young, Jim; Wang, Qing; Fux, Christoph Andreas; Bernasconi, Enos; Furrer, Hansjakob; Vernazza, Pietro; Calmy, A.; Cavassini, Matthias; Weber, Rainer; Battegay, Manuel; Bucher, Heiner C; Swiss HIV Cohort, Study (2014). The rate of recovery in renal function when patients with HIV infection discontinue treatment with tenofovir. HIV medicine, 15(8), pp. 505-510. Blackwell Science 10.1111/hiv.12149

Wang, Qing; Young, Jim; Bernasconi, Enos; Vernazza, Pietro; Calmy, Alexandra; Cavassini, Matthias; Furrer, Hansjakob; Fehr, Jan; Bucher, Heiner C; Battegay, Manuel; Swiss Hiv Cohort Study, SHCS (2014). Virologic and immunologic responses in treatment-naive patients to ritonavir-boosted atazanavir or efavirenz with a common backbone. HIV clinical trials, 15(3), pp. 92-103. Thomas Land Publishers 10.1310/hct1503-92

Wang, Qing; Young, Jim; Bernasconi, Enos; Cavassini, Matthias; Vernazza, Pietro; Hirschel, Bernard; Weber, Rainer; Furrer, Hansjakob; Stoeckle, Marcel; Bucher, Heiner C; Fux, Christoph Andreas; Swiss HIV, Cohort Study (2012). The prevalence of erectile dysfunction and its association with antiretroviral therapy in HIV-infected men: the Swiss HIV Cohort Study. Antiviral therapy, 18(3), pp. 337-344. London: International Medical Press 10.3851/IMP2372

Opportunistic Infections Project Team of the Collaboration of Ob, ; Young, Jim; Psichogiou, Mina; Meyer, Laurence; Ayayi, Sylvie; Grabar, Sophie; Raffi, Francois; Reiss, Peter; Gazzard, Brian; Sharland, Mike; Gutierrez, Félix; Obel, Niels; Kirk, Ole; Miro, José M; Furrer, Hansjakob; Castagna, Antonella; De Wit, Stéphane; Muñoz, Josefa; Kjaer, Jesper; Grarup, Jesper; ... (2012). CD4 cell count and the risk of AIDS or death in HIV-Infected adults on combination antiretroviral therapy with a suppressed viral load: a longitudinal cohort study from COHERE. PLoS medicine, 9(3), e1001194. San Francisco, Calif.: Public Library of Science 10.1371/journal.pmed.1001194

Young, Jim; Schäfer, Juliane; Fux, Christoph A; Furrer, Hansjakob; Bernasconi, Enos; Vernazza, Pietro; Calmy, Alexandra; Cavassini, Matthias; Weber, Rainer; Battegay, Manuel; Bucher, Heiner C; Swiss HIV Cohort Study, (2012). Renal function in patients with HIV starting therapy with tenofovir and either efavirenz, lopinavir or atazanavir. AIDS, 26(5), pp. 567-75. Hagerstown, Md.: Lippincott Williams & Wilkins 10.1097/QAD.0b013e32834f337c

Bucher, Heiner C; Rickenbach, Martin; Young, Jim; Glass, Tracy R; Vallet, Yannick; Bernasconi, Enos; Cavassini, Matthias; Fux, Christoph; Schiffer, Véronique; Vernazza, Pietro; Weber, Rainer; Battegay, Manuel; Swiss HIV Cohort Study, (2010). Randomized trial of a computerized coronary heart disease risk assessment tool in HIV-infected patients receiving combination antiretroviral therapy. Antiviral therapy, 15(1), pp. 31-40. London: International Medical Press 10.3851/IMP1475

Young, Jim; Bucher, Heiner C; Guenthard, Huldrych F; Rickenbach, Martin; Fux, Christoph A; Hirschel, Bernard; Cavassini, Matthias; Vernazza, Pietro; Bernasconi, Enos; Battegay, Manuel (2009). Virological and immunological responses to efavirenz or boosted lopinavir as first-line therapy for patients with HIV. Antiviral therapy, 14(6), pp. 771-9. London: International Medical Press 10.3851/IMP1291

Young, Jim; Glass, Tracy R; Bernasconi, Enos; Rickenbach, Martin; Furrer, Hansjakob; Hirschel, Bernard; Tarr, Philip E; Vernazza, Pietro; Battegay, Manuel; Bucher, Heiner C (2009). Hierarchical modeling gave plausible estimates of associations between metabolic syndrome and components of antiretroviral therapy. Journal of clinical epidemiology, 62(6), pp. 632-41. New York, N.Y.: Elsevier 10.1016/j.jclinepi.2008.07.015